REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ImplantTrade Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ImplantTrade Fogaszati es Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

ImplantTrade Kft. is based in Hungary. The head office is in Budapest. It operates in the Pharmacies and Drug Stores industry. It was established on November 01, 2008. There are currently 4 (2024) people employed by ImplantTrade Kft.. The company’s latest financial report indicates a net sales revenue increase of 42.55% in 2023. There was a total growth of 3.44% in ImplantTrade Kft.’s total assets over the same period. In 2023, ImplantTrade Kft.’s net profit margin decreased by 4.43%.

Headquarters
Csillaganizs utca 6. B. ep. foldszint 2.
Budapest; Budapest; Postal Code: 1037

Contact Details: Purchase the ImplantTrade Kft. report to view the information.

Basic Information
Total Employees:
Purchase the ImplantTrade Kft. report to view the information.
Outstanding Shares:
Purchase the ImplantTrade Kft. report to view the information.
Registered Capital:
Purchase the ImplantTrade Kft. report to view the information.
Incorporation Date:
November 01, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
BioLok Hungary Fogaszati Kereskedelmi Korlatolt Felelossegu Kt. a.
Company Performance
Financial values in the chart are available after ImplantTrade Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
42.55%▲
Total operating revenue
37.57%▲
Operating profit (EBIT)
-65.03%▼
EBITDA
-52.65%▼
Net Profit (Loss) for the Period
-57.98%▼
Total assets
3.44%▲
Total equity
20.67%▲
Operating Profit Margin (ROS)
-4.83%▼
Net Profit Margin
-4.43%▼
Return on Equity (ROE)
-32.06%▼
Quick Ratio
0.34%▲
Cash Ratio
0.25%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo